Oxidatively modified low density lipoprotein (Ox-LDL) is a known chemoattractant for monocytes. Here we demonstrate, using a modified Boyden chamber assay, that human peripheral blood T lymphocytes, but not B lymphocytes, also respond chemotactically to Ox-LDL, showing a threefold increase over control and an optimum response at 10 ;tg/ml. Copper and endothelial cell-oxidized LDL and #l-VLDL were used and gave similar results. The activity was not chemokinetic and native LDL possessed no chemoattractant activity. The chemoattractant activity was found to reside in the lipid fraction of Ox-LDL. Lysophosphatidylcholine is a major phospholipid component of Ox-LDL and is known to be chemotactic for monocytes. We show that lysophosphatidylcholine is also chemotactic for T lymphocytes with a maximal fourfold increase at 10 MM. Nonmetabolizable analogues of lysophosphatidylcholine had no such chemotactic effect. Thus, Ox-LDL, by virtue of its lysophosphatidylcholine content, may contribute to the recruitment of both T lymphocytes and monocytes into developing atherosclerotic lesions. (J. Clin. Invest. 1993. 92:1004-1008
Introduction
It has been recognized for some time that one of the earliest events in atherosclerotic lesion formation is the intimal accumulation of monocyte-derived macrophages and their subsequent development into foam cells (1) (2) (3) . Only recently, however, has the presence ofsubstantial numbers ofT lymphocytes been demonstrated in human fatty streaks, fibrous plaques, and advanced plaques (4) (5) (6) (7) (8) . Within the fibrous cap of human atherosclerotic lesions, T cells can represent up to 20% of the total cell population, while B lymphocytes or natural killer cells are rare (4) .
Studies in the cholesterol-fed rabbit model of atherosclerosis have been used to determine the sequence of lymphocyte and monocyte entry into the vessel wall. After only 1 wk of cholesterol feeding, both monocytes and T lymphocytes were found adhering to the aortic surface and accumulating within the lesion (9) . Finding that the infiltration of these two imflammatory cell types occurs at about the same time raises the possibility that they are responding to a common stimulus. While a number of chemoattractants have been suggested for the recruitment of monocytes, little is known about the factors that may influence T lymphocyte recruitment. Previous studies from this laboratory demonstrated that oxidized LDL (Ox-LDL)' is a potent chemoattractant for monocytes, but not for granulocytes. It was shown that lysophosphatidylcholine (lysoPtdCho), generated during the oxidation of LDL, was the major component responsible (10, 11) . These studies show that Ox-LDL, but not native LDL, is also a chemoattractant for circulating T lymphocytes. Furthermore, lyso-PtdCho was chemotactic for T cells, while neither Ox-LDL nor lyso-PtdCho showed any chemotactic activity for B lymphocytes. Thus, lyso-PtdCho, generated during oxidation of LDL or from the membrane phospholipids of damaged cells, could play a pivotal role in the recruitment of both monocytes and T lymphocytes not only into atherosclerotic lesions but also to sites of tissue injury and repair generally.
Methods
Materials. Ficoll ( 13) . These cells were maintained in Ham's F IO medium/ 15% FCS supplemented with epidermal growth factor at 10 ,ug/ml and used at confluence.
Lipoproteins. LDL (density = 1.019-1.063 g/ml) was isolated by ultracentrifugation from pooled normal human plasma collected in EDTA (1 mg/ml) (14) . Protein was determined by the method of Lowry et al. ( 15) using BSA as a standard. Copper-oxidized LDL was prepared by incubating LDL, at a concentration of 100 jg/ml, with 10 AM Cu2" in FIO medium at 370C for 24 h. Endothelial cell-modified LDL was prepared as previously described, using cultured rabbit aortic endothelial cells ( 16) . fl-VLDL was prepared from the plasma ofcholesterol-fed New Zealand White rabbits and VLDL from non-cholesterolfed rabbits as previously described ( 17 ) .
Lipidperoxidation. The extent of lipid peroxidation was measured as thiobarbituric acid reactive products (TBARS) and expressed as malondialdehyde (MDA) equivalents. Both native and f3-VLDL routinely had < 5 nmol MDA/mg protein, while the content of MDA in Ox-LDL samples (copper and endothelial cell-oxidized LDL) ranged from 50 to 70 nmol/mg protein.
Lipid extractions. Lipid extractions were carried out according to the method of Bligh and Dyer ( 18 ) . The chloroform phase was evaporated under nitrogen, the lipids were redissolved in ethanol, and aliquots were then added to HBSS for assessment in the chemotaxis assays.
Phospholipid analysis. Lipids were extracted from lipoproteins (200 jig of protein) with chloroform/methanol and the solvents were evaporated under nitrogen. The phospholipids were separated by TLC on silica gel G with chloroform/methanol/water, 65:35:6 (vol/vol/ vol) and visualized with iodine vapor. Phosphatidylcholine and lysoPtdCho were scraped from the plates and assayed for phosphorus content (19) .
Lyso-PtdCho and analogues. l-Palmitoyl-sn-glycerol-3-phosphocholine (lyso-PtdCho) was purchased from Sigma Chemical Co. The lyso-PtdCho analogues, l-palmityl-propanediol-3-phosphocholine, 1-palmityl-ethanediol-2-phosphocholine, and 1-palmitoyl-ethanediol-2-phosphocholine were a kind gift of Dr. W. J. Baumann (Hormel Institute, Austin, MN), prepared according to Murari et al. (20) and analyzed for purity using nuclear magnetic resonance spectroscopy. Analysis by TLC using a solvent system of CHC13/CH3OH/H20 (65:35:6, vol/vol/vol) indicated that all samples were pure and migrated as a single species. Samples were dried under N2 and resuspended in HBSS at appropriate concentrations for the chemotaxis assay.
Chemotaxis assay. Chemotaxis was measured in a 48-well modified Boyden microchemotaxis chamber (NeuroProbe) as described previously ( 16) . Assays were carried out in triplicate, using a 5-jim membrane. T lymphocytes were suspended in HBSS at 10 X 106 cells/ml and incubated at 37°C in a 5% CO2 atmosphere for 3 h. The filters were dehydrated and stained (LeukoStat; Fisher Diagnostics, Pittsburgh, PA) and then mounted on glass slides. The cells that had migrated to the underside of the filter were counted. Seven grid areas of 0.25 mm2 each were counted per sample. Chemotactic activity is expressed as a chemotactic index (CI), defined as the number of cells migrating in response to the test substance divided by the number migrating when control medium was present in both upper and lower chambers. The mean results are shown and are, in every case, representative oftwo or more replicate protocols.
Results
Effect ofoxidized LDL on T lymphocyte chemotaxis. Ox-LDL was prepared either by incubation with copper ion or by incubating overnight with a monolayer of endothelial cells. As shown in Fig. 1 , both forms ofOx-LDL were chemotactic for T lymphocytes, with more than a threefold increase in the number of migrating cells at a concentration of 10 jg/ml. The decrease in response at higher concentrations ofOx-LDL has ample precedent in the behavior of other chemoattractants and was not due to toxicity as determined by trypan blue exclusion after a 3-h incubation of T lymphocytes with up to 50 ,qg/ml (Table I) .
Effect ofOx-LDL on B lymphocyte chemotaxis. As shown in ( 11 ) . Consequently, lyso-PtdCho was tested using T lymphocytes as the target cells. Fig. 2 shows a fourfold increase in T lymphocyte migration in the presence of 5-10 jM lyso-PtdCho. This concentration lies well below the critical micellar concentration for lyso-PtdCho in HBSS and so is not due to a simple detergent effect. Furthermore, the effective concentration oflyso-PtdCho correlates well with the estimated lyso-PtdCho content of the effective concentration of Ox-LDL. Thus, 10 jg of Ox-LDL contains 2.5 nmol of lyso-PtdCho. In contrast, PtdCho possessed no chemoattractant activity for T lymphocytes.
3-VLDL is chemotactic for T lymphocytes. In the cholesterol-fed rabbit model of atherosclerosis, the major lipoprotein fraction is (-migrating very low density lipoprotein (fl-VLDL).
We have previously demonstrated that fl-VLDL is chemotactic for monocytes, probably by virtue of its high lyso-PtdCho content (17) . The f3-VLDL preparations contained, on average, 2.4 nmol of lyso-PtdCho/ 10 jig protein. Here, we show that f3-VLDL is also chemotactic for T lymphocytes (Fig. 3) . The maximal response was seen at 10 ,jg/ml and the magnitude of the response was comparable to that observed for Ox-LDL.
Extent ofoxidative modification, lyso-PtdCho content, and the ability ofmodifiedLDL to stimulate Tcell migration. The CI for each sample is expressed as mean±SD (seven fields counted per sample). Results are representative of those from two separate experiments.
maximal after 8 h when the formation of lyso-PtdCho also reached its plateau, suggesting a parallel between chemoattractant production and lyso-PtdCho formation. Lyso-PtdCho analogues and their chemotactic activity. Previous studies have suggested the potential involvement of a phospholipase C-type reaction in the monocyte chemotactic activity of lyso-PtdCho (21 ) . To ascertain whether metabolizable analogues of lyso-PtdCho would have effects similar to those of lyso-PtdCho itself, several analogues of lyso-PtdCho were studied: palmitoyl-ethanediol-2-phosphocholine, palmityl-ethanediol-2-phosphocholine, and palmityl-propanediol-2-phosphocholine. The first is a metabolizable analogue; the latter two having the palmitate in ether linkage rather than ester linkage are not metabolizable. Fig. 4 (6, 8) . They are especially prominent at the shoulders of more advanced lesions, in close association with macrophages, which are also present in high numbers in the shoulder regions (4, 7) . The chemotactic effect described here may, therefore, be relevant not only in the initial stages of lesion formation but throughout the history of the lesion. IL-1 has been demonstrated to be a chemoattractant for T cells (23, 24) and Ox-LDL has been shown to increase the secretion of IL-1 (25, 26) . Thus, there could be an indirect facilitation of T cell recruitment by Ox-LDL in addition to the direct effect demonstrated here.
It is possible that the chemotactic activity of Ox-LDL and f3-VLDL for T lymphocytes could be accounted for by its content of lyso-PtdCho, in consonance with our earlier findings regarding the chemotactic activity of Ox-LDL for monocytes (10, 11 ). Furthermore, the increase in extent of modification over time paralleled with the observed increase in lyso-PtdCho content and with the production of chemotactic activity for T lymphocytes. It has been previously reported that lyso-PtdCho is a chemoattractant for a murine thymic cell line and for concanavalin A-stimulated mouse spleen thymocytes (27) . The concentrations oflyso-PtdCho required, however, were 20-fold higher than the effective concentrations in the present studies and lyso-PtdCho was not effective for resting thymocytes. The reasons for the differences are not clear. Also of interest is the finding that concentrations of lyso-PtdCho increase in the artery wall early in the formation ofthe lesion (28) . Recent work from Dr. Michael Gimbrone's laboratory has shown that lysoPtdCho can induce the expression of an endothelial cell adhesion molecule, VCAM-1, on endothelial cells (29) . VCAM-1 is known to be involved in T lymphocyte adherence to endothelial cells (30) via a CD18-independent mechanism, and thus lyso-PtdCho may be involved in both the increased adherence and recruitment of T lymphocytes at sites of lesion formation. In these studies, as in our previous studies of the monocyte chemotactic response (21) , nonmetabolizable analogues of lyso-PtdCho were not chemotactic for T lymphocytes. This may reflect the need for further metabolism ofthe lyso-PtdCho in order for it to exert its chemotactic action. Alternatively, it may be that the concentration of nonmetabolizable analogues builds up in the plasma membrane and thereby erases any chemotactic gradient. Indeed, cells preincubated with the nonme- tabolizable analogues showed a significantly reduced ability to respond chemotactically to lyso-PtdCho (data not shown).
The role ofthe T lymphocyte in atherosclerotic lesion development has yet to be established. Recent studies show that the T cells in the lesion are polyclonal (31 ) and that they are in an activated state (22, 32 (34) . There are several lines of evidence suggesting that the oxidation of LDL by macrophages and endothelial cells can be attributed, in part, to the activity of 1 5-lipoxygenase (35) . The evidence includes the demonstration that the gene for 1 5-lipoxygenase is actively expressed in macrophage-rich areas of diffuse intimal thickening (36) . IL-4 is chemotactic for macrophages (37) . If it is also chemotactic for monocytes, there could be an interaction in which T cells help recruit additional macrophages, and vice versa. Furthermore, lymphocytes themselves have recently been shown capable of oxidizing LDL (38) . Thus, there could be an important interplay between T lymphocytes and macrophages, accelerating both the oxidative modification of LDL and the recruitment of additional T lymphocytes and monocytes.
While there are, as just outlined, several ways in which T lymphocyte-macrophage interactions might be proatherogenic, the situation is decidedly more complicated. This became clear from recent in vivo studies. Rats depleted of T lymphocytes, either athymic rats or normal rats injected with a monoclonal antibody against T cells, developed larger proliferative lesions after balloon injury than did control rats with normal T cell populations (39) . This suggests an antiatherogenic role for T lymphocytes. In contrast, rats injected with cyclosporin A, an inhibitor of T cell activation, were found to de-velop smaller lesions after balloon injury (40) . It is not clear, however, if the cyclosporin A itself had a direct effect on other components of the lesion. Thus, T cells could be, in principle, either proatherogenic or antiatherogenic. Only further in vivo experiments will be able to assign relative importance to the several possibilities suggested by studies in vitro.
